DJIA 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%

3.25 0.07 (2.20%)

Quote as of

company name or ticker

Recent Quotes

CYCC $3.25 2.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.27
Previous Close $3.18
Daily Range $3.13 - $3.30
52-Week Range $2.91 - $8.18
Market Cap $35.4M
P/E Ratio -1.25
Dividend (Yield) $0.00 (0.0%)
Volume 796,807
Average Daily Volume 290,194
Current FY EPS $0.00

Sector

Healthcare

Industry

Drugs

CYCLACEL PHARMACEUTICALS, INC. (CYCC) Description

A development-stage biopharmaceutical company dedicated to the discovery, development and eventual commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Website: http://www.cyclacel.com/

News & Commentary

Insiders at Lululemon and Restoration Hardware Sell Company Stock

Plus, there were noteworthy purchases at Ambit Biosciences and Cyclacel Pharmaceuticals.

Insiders at Lululemon and Restoration Hardware Sell Company Stock

Top Insider Trades: RH, AMBI, LULU, CYCC

Cyclacel Announces New Stock Issue

The pharmaceutical company hopes to reap gross proceeds of around $20 million from the offering.

U.S. HOT STOCKS FUTURES: HOT STOCKS TO WATCH

U.S. HOT STOCKS FUTURES: HOT STOCKS TO WATCH

Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock

Cyclacel Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript

A Bullish Argument For Cyclacel's Sapacitabine And Seamless

Reminder: Cyclacel Pharmaceuticals' 6% Preferred Stock Goes Ex-Dividend Soon

See More CYCC News...

CYCC's Top Competitors

CYCC $3.25 (2.20%)
Current stock: CYCC
AMGN $105.91 (0.27%)
Current stock: AMGN
GILD $55.81 (0.59%)
Current stock: GILD
BIIB $235.24 (1.13%)
Current stock: BIIB